Anemia
Conference Coverage
Opioids appear safe for sickle cell pain
SAN DIEGO – For sickle cell patients, opioid-related mortality is essentially a “never” event.
Video
Novel conditioning and familial haploidentical SCT well tolerated, cured 90% of patients
SAN DIEGO – A novel conditioning regimen with familial haploidentical stem cell transplantation shows promise for high-risk sickle cell disease....
Video
New treatments promise sickle cell “cure” for all ages
SAN DIEGO – Dr. Ify Osunkwo described the latest approaches, from gene therapy to haploidentical stem cell transplant, as well as patient access...
Conference Coverage
Sickle cell disease phenotype reversed by gene therapy
SAN DIEGO – Genetically modified autologous stem cells increased protective fetal hemoglobin and decreased sickle hemoglobin in an adult with...
Conference Coverage
Daily hydroxyurea effective, safe for African children
SAN DIEGO – Hydroxyurea was associated with reduced rates of malaria and in other infections, resulting in improved survival.
Video
Flipping the fetal hemoglobin switch reverses sickle cell symptoms
SAN DIEGO – One adult with sickle cell disease had near-complete remission of symptoms after 6 months of follow-up.
Conference Coverage
Your guide to ASH 2018: Abstracts to watch
News
Pegfilgrastim biosimilar approved by EC
The European Commission (EC) has granted marketing authorization for Sandoz’s pegfilgrastim product Ziextenzo®, a biosimilar of Amgen’s Neulasta...
News
EC approves pegfilgrastim biosimilar
The European Commission (EC) has approved Mundipharma’s pegfilgrastim product Pelmeg, a biosimilar of Amgen’s Neulasta. Pelmeg is approved for...
News
Ins and outs of SCD treatment to be covered at ASH
Sickle cell disease (SCD) will take center stage at the 2018 ASH Annual Meeting, according to a recent press briefing. During the briefing, ASH...
Conference Coverage
ASH 2018 coming attractions look at the big picture
Big trials, big results in malignant and nonmalignant hematologic disorders are on the program at the 2018 ASH annual meeting.